| Feb 19, 2026 |
Feb 20, 2026 |
Rozek Elizabeth
|
Chief Legal & Admin. Officer |
Neutral |
90.0
|
+44,000
|
23.04%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Neutral |
90.0
|
+44,000
|
42.60%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Happel David
|
CEO |
Neutral |
90.0
|
+128,000
|
18.89%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Chauche Thierry
|
CFO |
Neutral |
90.0
|
+44,000
|
280.47%
|
✗
|
- |
| Feb 10, 2026 |
Feb 12, 2026 |
Happel David
|
CEO |
Sell |
42.5
|
-12,101
|
-1.75%
|
✗
|
$64.9K |
| Feb 10, 2026 |
Feb 12, 2026 |
Chauche Thierry
|
CFO |
Sell |
47.5
|
-1,312
|
-7.72%
|
✗
|
$7K |
| Feb 10, 2026 |
Feb 12, 2026 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Sell |
46.3
|
-3,640
|
-3.40%
|
✗
|
$19.5K |
| Feb 10, 2026 |
Feb 12, 2026 |
Rozek Elizabeth
|
Chief Legal & Admin. Officer |
Sell |
46.3
|
-2,622
|
-1.35%
|
✗
|
$14.1K |
| Nov 20, 2025 |
Nov 21, 2025 |
Kemble George
|
Chair |
Sell |
7.5
|
-37,688
|
-31.75%
|
✓
|
$290K |
| Nov 4, 2025 |
Nov 6, 2025 |
Rozek Elizabeth
|
Chief Legal & Admin. Officer |
Neutral |
85.0
|
+9,855
|
5.36%
|
✗
|
- |
| Jul 21, 2025 |
Jul 23, 2025 |
Happel David
|
CEO |
Sell |
40.0
|
-65,478
|
-8.67%
|
✗
|
$598.1K |
| Jul 21, 2025 |
Jul 23, 2025 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Sell |
42.5
|
-8,277
|
-7.18%
|
✗
|
$75.6K |
| Jul 21, 2025 |
Jul 23, 2025 |
Rozek Elizabeth
|
General Counsel and CCO |
Sell |
42.5
|
-10,780
|
-5.54%
|
✗
|
$98.5K |
| Jun 9, 2025 |
Jun 10, 2025 |
Walbert Timothy P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
SEIDENBERG BETH C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2025 |
Jun 10, 2025 |
Phillips Anne M.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2025 |
Jun 10, 2025 |
Kemble George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2025 |
Jun 10, 2025 |
Jarrett Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2025 |
Jun 10, 2025 |
Hoelscher Paul W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2025 |
Jun 10, 2025 |
GRAMMER ELIZABETH A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2025 |
Feb 7, 2025 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Neutral |
90.0
|
+34,000
|
41.87%
|
✗
|
- |
| Feb 6, 2025 |
Feb 7, 2025 |
Happel David
|
CEO |
Neutral |
90.0
|
+116,000
|
18.15%
|
✗
|
- |
| Feb 6, 2025 |
Feb 7, 2025 |
Rozek Elizabeth
|
General Counsel and CCO |
Neutral |
90.0
|
+34,000
|
21.18%
|
✗
|
- |
| Feb 6, 2025 |
Feb 7, 2025 |
Chauche Thierry
|
CFO |
Neutral |
90.0
|
+17,000
|
100.00%
|
✗
|
- |
| Aug 1, 2024 |
Aug 5, 2024 |
Jarrett Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 1, 2024 |
Aug 5, 2024 |
Phillips Anne M.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 5, 2024 |
Jarrett Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 5, 2024 |
Phillips Anne M.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 23, 2024 |
Jul 25, 2024 |
Kemble George
|
Chair |
Sell |
20.0
|
-23,625
|
-16.60%
|
✓
|
$74.8K |
| Jul 19, 2024 |
Jul 23, 2024 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Sell |
46.3
|
-8,357
|
-9.33%
|
✗
|
$25.9K |
| Jul 19, 2024 |
Jul 23, 2024 |
Rozek Elizabeth
|
General Counsel and CCO |
Sell |
46.3
|
-10,914
|
-6.37%
|
✗
|
$33.8K |
| Jul 19, 2024 |
Jul 23, 2024 |
Kemble George
|
Chair |
Sell |
46.3
|
-14,062
|
-8.99%
|
✗
|
$43.6K |
| Jun 5, 2024 |
Jun 7, 2024 |
Walbert Timothy P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
SEIDENBERG BETH C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Parsey Merdad
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Hoelscher Paul W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
GRAMMER ELIZABETH A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 6, 2024 |
May 8, 2024 |
Chauche Thierry
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 8, 2024 |
Chauche Thierry
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2024 |
Apr 3, 2024 |
Walbert Timothy P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2024 |
Apr 3, 2024 |
Hoelscher Paul W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 3, 2024 |
Walbert Timothy P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 3, 2024 |
Hoelscher Paul W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 26, 2024 |
Mar 28, 2024 |
Happel David
|
CEO |
Buy |
82.5
|
+12,100
|
1.93%
|
✗
|
$63.7K |
|
Feb 2, 2024 |
Oriti Joseph
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2024 |
Jan 31, 2024 |
SANDELL SCOTT D
|
10% Owner |
Neutral |
27.5
|
-843,003
|
-21.89%
|
✗
|
- |
| Jan 29, 2024 |
Jan 31, 2024 |
KERINS PATRICK J
|
10% Owner |
Neutral |
27.5
|
-836,861
|
-21.74%
|
✗
|
- |
| Jan 29, 2024 |
Jan 31, 2024 |
BASKETT FOREST
|
10% Owner |
Neutral |
27.5
|
-838,700
|
-21.78%
|
✗
|
- |
| Jan 29, 2024 |
Jan 31, 2024 |
NEA Partners 13, Limited Partnership
|
10% Owner |
Neutral |
27.5
|
-850,000
|
-22.08%
|
✗
|
- |
| Jan 29, 2024 |
Jan 31, 2024 |
NEW ENTERPRISE ASSOCIATES 13 LP
|
10% Owner |
Neutral |
27.5
|
-850,000
|
-22.08%
|
✗
|
- |
| Dec 7, 2023 |
Dec 8, 2023 |
Happel David
|
CEO |
Buy |
60.0
|
+1,600
|
0.26%
|
✗
|
$6.6K |
| Nov 17, 2023 |
Nov 21, 2023 |
Rozek Elizabeth
|
General Counsel and CCO |
Neutral |
90.0
|
+171,420
|
100.00%
|
✗
|
- |
| Nov 17, 2023 |
Nov 21, 2023 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Neutral |
90.0
|
+89,570
|
100.00%
|
✗
|
- |
| Nov 17, 2023 |
Nov 21, 2023 |
Kemble George
|
Chair |
Neutral |
90.0
|
+150,750
|
2677.62%
|
✗
|
- |
| Nov 17, 2023 |
Nov 21, 2023 |
Happel David
|
CEO |
Neutral |
90.0
|
+624,910
|
105916.95%
|
✗
|
- |
| Nov 16, 2023 |
Nov 20, 2023 |
Happel David
|
CEO |
Buy |
90.0
|
+590
|
100.00%
|
✗
|
$1.4K |
| Sep 7, 2023 |
Sep 8, 2023 |
Kemble George
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
NEW ENTERPRISE ASSOCIATES 13 LP
|
10% Owner |
Buy |
67.5
|
+29,338
|
0.38%
|
✗
|
$469.4K |
| Jul 18, 2023 |
Jul 20, 2023 |
KPCB PBD Associates, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
SEIDENBERG BETH C
|
Director |
Buy |
97.5
|
+46,875
|
120.93%
|
✗
|
$750K |
| Jul 18, 2023 |
Jul 20, 2023 |
Wu Jinzi Jason
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Rozek Elizabeth
|
General Counsel and CCO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Rodgers Richard J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Rimac Anthony M
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Parsey Merdad
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Martins Eduardo Bruno
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Kemble George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Hom Dennis
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
Happel David
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2023 |
Jul 20, 2023 |
GRAMMER ELIZABETH A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
NEW ENTERPRISE ASSOCIATES 13 LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
KPCB PBD Associates, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
SEIDENBERG BETH C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Wu Jinzi Jason
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Rozek Elizabeth
|
General Counsel and CCO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Rodgers Richard J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Rimac Anthony M
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Parsey Merdad
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Martins Eduardo Bruno
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Kemble George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Happel David
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Hom Dennis
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
GRAMMER ELIZABETH A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |